How do mood stabilizers work
Pro Research Analysisby 
Searched over 200M research papers
Mechanisms of Mood Stabilizers in Bipolar Disorder
Introduction to Mood Stabilizers
Mood stabilizers are a class of medications primarily used to treat bipolar disorder, a mental health condition characterized by recurrent episodes of mania and depression. These drugs are essential for managing both the acute phases of the disorder and for preventing future episodes Harwood2003Schloesser2012Bachmann2005. The most well-known mood stabilizers include lithium, valproic acid (VPA), and carbamazepine Harwood2003Bachmann2005Gould2002.
Lithium: Inhibition of GSK-3 and Inositol Signaling
Lithium is one of the most established mood stabilizers and has been shown to have significant effects on both manic and depressive episodes Harwood2003Bauer2004. Lithium works by directly inhibiting two key signal transduction pathways: inositol signaling and glycogen synthase kinase-3 (GSK-3) Harwood2003Bachmann2005. GSK-3 is a multifunctional protein kinase involved in various neuronal functions, and its inhibition by lithium is believed to contribute to its mood-stabilizing effects Harwood2003Bachmann2005. Additionally, lithium's suppression of inositol signaling through the depletion of intracellular inositol is another mechanism that may underlie its therapeutic effects Harwood2003Bachmann2005.
Valproic Acid: Histone Deacetylase Inhibition and Neuroprotection
Valproic acid (VPA) is another widely used mood stabilizer that shares some mechanisms with lithium but also has unique actions. VPA indirectly reduces GSK-3 activity and inhibits histone deacetylase (HDAC), leading to up-regulation of gene expression Harwood2003Chiu2013Bachmann2005. These actions contribute to its neuroprotective and neurotrophic effects, which are beneficial in treating bipolar disorder and potentially other central nervous system diseases Chiu2013Bachmann2005Chuang2005. VPA also inhibits inositol signaling, similar to lithium, further supporting its role in mood stabilization Harwood2003Bachmann2005.
Carbamazepine: Neuronal Morphology and Inositol Depletion
Carbamazepine, another antiepileptic drug with mood-stabilizing properties, does not inhibit GSK-3 but alters neuronal morphology through an inositol-depletion mechanism Harwood2003Bachmann2005. This mechanism is similar to that of lithium and VPA, suggesting a common pathway in mood stabilization Harwood2003Bachmann2005.
Cellular Plasticity and Resilience
Mood stabilizers like lithium, VPA, and carbamazepine have been shown to regulate factors involved in cell survival pathways, including cyclic adenine monophosphate response element-binding protein (CREB), brain-derived neurotrophic factor (BDNF), and mitogen-activated protein kinases (MAPKs) Bachmann2005Gould2002. These drugs enhance cellular plasticity and resilience, which are crucial for their therapeutic effects in bipolar disorder Bachmann2005Gould2002.
Neuroprotective and Antiapoptotic Actions
Emerging evidence suggests that mood stabilizers have significant neuroprotective and antiapoptotic actions. Lithium and VPA protect against glutamate-induced excitotoxicity and other forms of neuronal stress by activating cell survival pathways and inducing neuroprotective proteins like Bcl-2 and heat-shock proteins (HSPs) . These actions contribute to their efficacy in treating not only bipolar disorder but also other neurodegenerative conditions Chiu2013Chuang2005.
Conclusion
Mood stabilizers such as lithium, valproic acid, and carbamazepine are essential in the treatment of bipolar disorder. Their mechanisms of action include the inhibition of GSK-3, inositol signaling, and HDAC, as well as the enhancement of cellular plasticity and resilience. These drugs also exhibit neuroprotective and antiapoptotic properties, making them valuable in managing bipolar disorder and potentially other neurological conditions. Understanding these mechanisms can guide the development of more effective treatments with fewer side effects.
Sources and full results
Most relevant research papers on this topic